NCT03228667 2026-01-14QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsImmunityBio, Inc.Phase 2 Active not recruiting40 enrolled
NCT05714553 2025-07-18NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plcPhase 1/2 Terminated19 enrolled
NCT01803503 2016-06-22Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid TumorsNational University Hospital, SingaporePhase 2 Unknown80 enrolled
NCT01172028 2015-12-03Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsUniversity of ArizonaPhase 1 Completed33 enrolled
NCT00539968 2015-02-05A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)Merck Sharp & Dohme LLCPhase 1/2 Terminated5 enrolled
NCT00511576 2015-01-08Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsMirati Therapeutics Inc.Phase 1 Terminated54 enrolled
NCT00014456 2013-08-28Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsDartmouth-Hitchcock Medical CenterPhase 1 Completed35 enrolled
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled